Log in

NASDAQ:CNCEConcert Pharmaceuticals Insider Trades

$10.09
-0.08 (-0.79 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.93
Now: $10.09▼
$10.38
50-Day Range
$9.01
MA: $9.91▼
$11.52
52-Week Range
$5.36
Now: $10.09▼
$13.09
Volume119,000 shs
Average Volume160,899 shs
Market Capitalization$299.17 million
P/E RatioN/A
Dividend YieldN/A
Beta0.91

Insider Trades

Concert Pharmaceuticals (NASDAQ:CNCE) Insider Buying and Selling Activity

Insider Ownership Percentage: 11.00%

Insider Buying and Selling by Quarter


Concert Pharmaceuticals (NASDAQ CNCE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/22/2020Nancy StuartCOOSell10,295$11.34$116,745.30167,924  
3/12/2020Thomas G AuchinclossDirectorBuy1,500$8.52$12,780.006,500  
2/3/2020Thomas G AuchinclossDirectorBuy1,000$10.91$10,910.005,000  
10/8/2019Heek Christi VanDirectorBuy5,000$5.90$29,500.005,000  
8/8/2019Peter Barton HuttDirectorSell3,539$10.31$36,487.097,963  
8/2/2019Heek Christi VanDirectorBuy5,000$10.84$54,200.005,000  
6/10/2019Bvf Partners L P/IlMajor ShareholderSell386,289$10.70$4,133,292.30  
11/15/2018Richard AldrichDirectorBuy50,000$11.83$591,500.00296,975  
7/10/2018Nancy StuartCOOSell31,418$17.87$561,439.66116,085  
4/17/2018James V CassellaInsiderSell10,582$20.18$213,544.7630,000  
2/1/2018Richard AldrichDirectorSell11,946$20.89$249,551.94286,975  
1/29/2018Richard AldrichDirectorSell18,054$20.63$372,454.02286,975  
1/26/2018Richard AldrichDirectorSell5,000$20.46$102,300.00286,975  
1/24/2018Richard AldrichDirectorSell30,000$19.68$590,400.00286,975  
1/22/2018Richard AldrichDirectorSell10,000$19.55$195,500.00286,975  
1/19/2018Richard AldrichDirectorSell30,000$19.35$580,500.00286,975  
1/16/2018Richard AldrichDirectorSell31,236$19.14$597,857.04286,975  
12/19/2017Value Fund L P BiotechnologyInsiderSell1,282,856$26.65$34,188,112.40  
12/4/2017Ronald W BarrettDirectorSell14,156$24.70$349,653.203,539  
10/19/2017Value Fund L P BiotechnologyInsiderBuy331,916$15.84$5,257,549.44  
9/14/2017Ryan LynchInsiderSell3,500$14.51$50,785.009,500  
5/12/2016Thomas G AuchinclossDirectorBuy2,000$10.11$20,220.002,000  
5/11/2016Roger D TungCEOBuy19,610$10.55$206,885.50538,965  
12/16/2015Wilfred E JaegerDirectorSell10,360$19.57$202,745.20  
12/15/2015Wilfred E JaegerDirectorSell54,572$20.10$1,096,897.20  
12/14/2015Pauline McgowanVPSell498$20.07$9,994.86  
12/14/2015Wilfred E JaegerDirectorSell3,922$20.09$78,792.98  
11/9/2015Ronald W. BarrettDirectorSell17,699$22.27$394,156.73  
11/2/2015Nancy StuartCOOSell23,216$24.29$563,916.6425,004  
9/18/2015Robert SilvermanVPSell10,000$20.00$200,000.0010,000  
9/10/2015Wilfred E JaegerDirectorSell120,000$18.22$2,186,400.00  
8/18/2015Wilfred E JaegerDirectorSell760,000$15.81$12,015,600.00  
8/13/2015Wilfred E JaegerDirectorSell92,215$16.75$1,544,601.25  
8/12/2015Wilfred E JaegerDirectorSell97,785$17.49$1,710,259.65  
6/8/2015Robert SilvermanVPSell5,000$16.35$81,750.00  
3/11/2015Nancy StuartCOOSell46,430$15.00$696,450.00  
3/11/2015Pauline McgowanVPSell5,973$16.00$95,568.00  
3/10/2015Pauline McgowanVPSell22,122$13.90$307,495.80  
11/18/2014Three Arch Management Iv, L.L.DirectorSell250,000$12.29$3,072,500.00  
2/20/2014Skyline Venture Partners QualiMajor ShareholderBuy150,000$14.00$2,100,000.00  
2/19/2014Life Science Ventures Vi G TvmDirectorBuy89,000$14.00$1,246,000.00  
2/19/2014Plc GlaxosmithklineMajor ShareholderBuy35,000$14.00$490,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.